Xitra Therapeutics
Pre-clinicalXitra Therapeutics develops small molecule therapeutics targeting protein-protein interactions for oncology and inflammatory diseases.
Founded
2018
Focus
Small Molecules
About
Xitra Therapeutics develops small molecule therapeutics targeting protein-protein interactions for oncology and inflammatory diseases.
Company Info
TypePrivate
Founded2018
LocationMunich, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile